Literature DB >> 28531811

Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities.

Elizabeth Almeida Lafayette1, Sinara Mônica Vitalino de Almeida2, Renata Virginia Cavalcanti Santos3, Jamerson Ferreira de Oliveira4, Cezar Augusto da Cruz Amorim4, Rosali Maria Ferreira da Silva5, Maira Galdino da Rocha Pitta3, Ivan da Rocha Pitta3, Ricardo Olimpio de Moura6, Luiz Bezerra de Carvalho Júnior7, Moacyr Jesus Barreto de Melo Rêgo3, Maria do Carmo Alves de Lima4.   

Abstract

Molecules bearing indole nucleus present diverse biological properties such as antitumor and anti-inflammatory activities that can be associated both to DNA and protein interactions. This study focused on the synthesis of new indole derivatives with thiazolidines and imidazolidine rings condensed as side chains as well as the evaluation of their ability to interact with the DNA and antitumor and topoisomerase inhibition activities. All derivatives were successfully synthesized and their structures were elucidated by mass spectrometry (MS), infrared (IR), spectroscopy 1H NMR, 13C NMR, COSY 1H-1H and HSQC 1H-13C. The antitumor activity was evaluated against different cancer cell lines using the antiproliferative MTT assay. DNA binding ability was analyzed by absorption spectroscopy and fluorescence technique using ethidium bromide (EB) as a fluorescent probe. Changes were observed in spectroscopic properties of the compounds after interacting with ctDNA (calf thymus DNA), with hypochromic and hyperchromic effects, besides blue or red shifts in the maxima of spectra. The indole derivative 5-(1H-Indol-3-ylmethylene)-thiazolidin-2,4-dione (4c) presented the best results in antitumor assay against the breast line tested (T47D), with IC50 value lower than the positive control, doxorubicin (1.93 and 4.61 μM, respectively). On the other hand, the compound 3-amino-5-(1H-indol-3-ylmethylene)-2-thioxo-thiazolidin-4-one (4a) was active against leukemia cell lines (HL60 and K562) with the high value of the DNA binding constant, Kb of 5.69 × 104. However, this compound (4a) did not inhibit the topoisomerase-I activity evaluated by relaxation assay. These results show that the indole nucleus contribute to the incorporation of molecules into the DNA. Moreover, it was highlighted that basic side chains, such as thiazolidines and imidazolidines, and free amino group, are relevant for design of promising antitumor and DNA binding compounds.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antitopoisomerase; Antitumor; DNA; Indole

Mesh:

Substances:

Year:  2017        PMID: 28531811     DOI: 10.1016/j.ejmech.2017.05.012

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Design, synthesis, and DNA interaction studies of furo-imidazo[3.3.3]propellane derivatives: Potential anticancer agents.

Authors:  Alaa A Hassan; Ashraf A Aly; Nasr K Mohamed; Kamal M El Shaieb; Maysa M Makhlouf; El-Shimaa M N Abdelhafez; Stefan Bräse; Martin Nieger; Kevin N Dalby; Tamer S Kaoud
Journal:  Bioorg Chem       Date:  2019-02-13       Impact factor: 5.275

2.  5-(1H-Indol-3-ylmethylene)-4-oxo-2-thioxothiazolidin-3-yl)alkancarboxylic Acids as Antimicrobial Agents: Synthesis, Biological Evaluation, and Molecular Docking Studies.

Authors:  Volodymyr Horishny; Victor Kartsev; Athina Geronikaki; Vasyl Matiychuk; Anthi Petrou; Jasmina Glamoclija; Ana Ciric; Marina Sokovic
Journal:  Molecules       Date:  2020-04-23       Impact factor: 4.411

3.  Microindoline 581, an Indole Derivative from Microbacterium Sp. RP581 as A Novel Selective Antineoplastic Agent to Combat Hepatic Cancer Cells: Production, Optimization and Structural Elucidation.

Authors:  Roya Pournejati; Ronald Gust; Brigitte Kircher; Hamid Reza Karbalaei-Heidari
Journal:  Iran J Pharm Res       Date:  2020       Impact factor: 1.696

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.